# | Title | Journal | Year | Citations |
---|
1 | DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHY | Lancet, The | 1981 | 153 |
2 | Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. | Heart | 1993 | 151 |
3 | Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II | Journal of Hypertension | 1993 | 133 |
4 | Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor | Biochemical and Biophysical Research Communications | 1989 | 121 |
5 | Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers. | Circulation Research | 1992 | 77 |
6 | Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm | American Journal of Cardiology | 1987 | 76 |
7 | Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the “practical” Study) | American Journal of Cardiology | 1994 | 63 |
8 | Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension | Journal of Hypertension | 1993 | 60 |
9 | Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarction | Clinical Endocrinology | 1994 | 54 |
10 | Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in Man | PACE - Pacing and Clinical Electrophysiology | 1993 | 48 |
11 | Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension. | Hypertension | 1993 | 48 |
12 | Impact of Obesity on Diastolic Function in Subjects ≤16 Years of Age | American Journal of Cardiology | 2006 | 48 |
13 | Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension. | Hypertension | 1993 | 40 |
14 | Long-Term Outcomes of Childhood Left Ventricular Noncompaction Cardiomyopathy | Circulation | 2018 | 38 |
15 | Prolonged inhibition of endopeptidase 24.11 in normal man | Journal of Hypertension | 1991 | 33 |
16 | Verapamil in the Management of Hypertensive Patients | Australian and New Zealand Journal of Medicine | 1979 | 32 |
17 | Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels. | Hypertension | 1989 | 31 |
18 | Neurohumoral changes during onset and offset of ovine heart failure: role of ANP | American Journal of Physiology - Heart and Circulatory Physiology | 1989 | 29 |
19 | Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris | American Journal of Cardiology | 1990 | 29 |
20 | Endothelin-induced changes in intracellular calcium concentration in rat vascular smooth muscle cells: Effects of extracellular calcium and atrial natriuretic factor | Heart and Vessels | 1992 | 27 |
21 | Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines. | Heart | 1990 | 25 |
22 | The natriuretic peptides and hypertension | Journal of Internal Medicine | 1994 | 24 |
23 | Echocardiographic Demonstration of Tricuspid Valvulitis and Right Atrial Thrombus Complicating an Infected Artificial Pacemaker: A Case Report | Angiology | 1978 | 23 |
24 | ATRIAL NATRIURETIC PEPTIDE LEVELS IN CONGESTIVE HEART FAILURE IN MAN BEFORE AND DURING CONVERTING ENZYME INHIBITION | Clinical and Experimental Pharmacology and Physiology | 1989 | 23 |
25 | Hemodynamic and hormone changes during induced ventricular tachycardia secondary to coronary artery disease | American Journal of Cardiology | 1989 | 21 |
26 | Flecainide in the Wolff-Parkinson-White syndrome | American Journal of Cardiology | 1992 | 19 |
27 | Hemodynamic effects of nitroprusside on valvular aortic stenosis | American Journal of Cardiology | 1992 | 18 |
28 | Long-Term Outcomes of Total Anomalous Pulmonary Venous Drainage Repair in Neonates and Infants | Annals of Thoracic Surgery | 2018 | 18 |
29 | Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine. | Heart | 1994 | 17 |
30 | Global and Regional Hemodynamic Effects of Ramipril in Congestive Heart Failure | Journal of Cardiovascular Pharmacology | 1989 | 14 |
31 | Comparison of the Effect of Renin Inhibition and Angiotensin-Converting Enzyme Inhibition in Ovine Heart Failure | Journal of Cardiovascular Pharmacology | 1992 | 13 |
32 | Hemodynamic and hormonal effects of renin inhibition in ovine heart failure | American Journal of Physiology - Heart and Circulatory Physiology | 1990 | 11 |
33 | Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure | Journal of Cardiovascular Pharmacology | 1992 | 11 |
34 | The non-invasive recognition of left atrial enlargement: comparison of electro- and echocardiographic measurements | Postgraduate Medical Journal | 1977 | 10 |
35 | Renal Effects of ACE Inhibition in Ovine Heart Failure: A Comparison of Intermittent and Continuous ACE Inhibition | Journal of Cardiovascular Pharmacology | 1990 | 9 |
36 | Acute Hemodynamic, Hormonal, and Renal Effects of Neutral Endopeptidase Inhibition in Ovine Heart Failure | Journal of Cardiovascular Pharmacology | 1992 | 9 |
37 | Angiotensin II receptor antagonism in ovine heart failure: acute hemodynamic, hormonal, and renal effects | American Journal of Physiology - Heart and Circulatory Physiology | 1992 | 9 |
38 | THE PATTERN OF ATRIAL NATRIURETIC PEPTIDE RELEASE DURING VENTRICULAR TACHYCARDIA IN MAN | Clinical and Experimental Pharmacology and Physiology | 1987 | 8 |
39 | Converting enzyme inhibitors in heart failure | European Heart Journal | 1988 | 8 |
40 | Primary Amyloidosis with Cardiac Involvement Diagnosed by Left Ventricular Endomyocardial Biopsy | Australian and New Zealand Journal of Medicine | 1977 | 7 |
41 | ANP Infusion in the Treatment of Heart Failure and Comparison with ACE Inhibition | Journal of Cardiovascular Pharmacology | 1990 | 7 |
42 | Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina | American Journal of Cardiology | 1992 | 7 |
43 | Inefficacy of daily single bolus dose atrial natriuretic factor in chronic congestive heart failure | American Journal of Cardiology | 1989 | 6 |
44 | ACUTE THROMBOTIC OBSTRUCTION OF A MITRAL VALVE PROSTHESIS: THE ROLE OF THROMBOLYTIC THERAPY | Australian and New Zealand Journal of Medicine | 1988 | 5 |
45 | Elevated atrial natriuretic factor in the plasma: cause or effect in “idiopathic orthostatic hypotension”? | International Journal of Cardiology | 1990 | 5 |
46 | Metabolic and Psychological Impact of a Pragmatic Exercise Intervention Program in Adolescent and Young Adult Survivors of Pediatric Cancer-Related Cerebral Insult | Journal of Adolescent and Young Adult Oncology | 2018 | 5 |
47 | Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects | Journal of Hypertension | 1991 | 5 |
48 | Myocardial function in alcoholic cardiac beriberi | International Journal of Cardiology | 1987 | 4 |
49 | The early diagnosis of acute myocardial infarction | Australian and New Zealand Journal of Medicine | 1991 | 4 |
50 | Atrial natriuretic factor administered to humans: 1984-1988 | Journal of Cardiovascular Pharmacology | 1989 | 3 |